Latest Lion Point Capital, LP Stock Portfolio

$16.73Million | No. of Holdings #35

Lion Point Capital, LP Performance

2026 Q1-10.87%

YTD-10.87%

2025+17.04%

About Lion Point Capital, LP and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Lion Point Capital, LP reported an equity portfolio of $16.7 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Lion Point Capital, LP are PRAX, MLTX, RPRX. The fund has invested 8.6% of it's portfolio in PRAXIS PRECISION MEDICINES I and 7.5% of portfolio in MOONLAKE IMMUNOTHERAPEUTICS. <br><br> The fund managers got completely rid off DAY ONE BIOPHARMACEUTICALS I (DAWN), VENTYX BIOSCIENCES INC (VTYX) and MINERVA NEUROSCIENCES INC (NERV) stocks. The fund showed a lot of confidence in some stocks as they added substantially to COMPASS PATHWAYS PLC (CMPS), HUMACYTE INC (HUMA) and MILESTONE PHARMACEUTICALS IN (MIST).

Lion Point Capital, LP Equity Portfolio Value

Last Reported on: 15 May, 2026

$16.73Million

as of May 15, 2026

Lion Point Capital, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Lion Point Capital, LP made a return of -10.87% in the last quarter. In trailing 12 months, it's portfolio return was 27.97%.

Performance
S&P 500

New Buys

No new stocks were added by Lion Point Capital, LP

Additions

Ticker	% Inc.
compass pathways plc	37.93
humacyte inc	30.00
milestone pharmaceuticals in	8.61

Additions to existing portfolio by Lion Point Capital, LP

Reductions

None of the existing positions were reduced by Lion Point Capital, LP

Sold off

Ticker	$ Sold
day one biopharmaceuticals i	-391,440
ventyx biosciences inc	-374,745
minerva neurosciences inc	-140,700
mersana therapeutics inc	-2,893

Lion Point Capital, LP got rid off the above stocks

Sector Distribution

Lion Point Capital, LP has about 91.1% of it's holdings in Healthcare sector.

Healthcare
Others

Sector	%
Healthcare	91.1
Others	8.9

Market Cap. Distribution

Lion Point Capital, LP has about 10.6% of it's portfolio invested in the large-cap and mega-cap stocks.

SMALL-CAP
MID-CAP
MICRO-CAP
LARGE-CAP
UNALLOCATED
NANO-CAP

Category	%
SMALL-CAP	45.2
MID-CAP	15.5
MICRO-CAP	14.4
LARGE-CAP	10.6
UNALLOCATED	8.9
NANO-CAP	5.5

Stocks belong to which Index?

About 47.2% of the stocks held by Lion Point Capital, LP either belong to S&P 500 or RUSSELL 2000 index.

Others
RUSSELL 2000
S&P 500

Index	%
Others	52.7
RUSSELL 2000	45
S&P 500	2.2

Top 5 Winners (%)		%
MLTX	moonlake immunotherapeutics	41.4 %
EWTX	edgewise therapeutics inc	26.9 %
RPRX	royalty pharma plc	24.1 %
INVA	innoviva inc	16.6 %
LNTH	lantheus hldgs inc	14.0 %

Top 5 Winners ($)		$
MLTX	moonlake immunotherapeutics	0.4 M
RPRX	royalty pharma plc	0.2 M
PRAX	praxis precision medicines i	0.1 M
GERN	geron corp	0.1 M
SNDX	syndax pharmaceuticals inc	0.1 M

Top 5 Losers (%)		%
JSPR	jasper therapeutics inc	-52.1 %
RGNX	regenxbio inc	-41.8 %
MCRB	seres therapeutics inc	-40.4 %
MIST	milestone pharmaceuticals in	-40.1 %
AZTA	azenta inc	-36.5 %

Top 5 Losers ($)		$
MIST	milestone pharmaceuticals in	-0.7 M
JSPR	jasper therapeutics inc	-0.4 M
HUMA	humacyte inc	-0.2 M
MCRB	seres therapeutics inc	-0.2 M
BNTC	benitec biopharma inc	-0.2 M

Lion Point Capital, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Lion Point Capital, LP

Lion Point Capital, LP has 35 stocks in it's portfolio. About 54.6% of the portfolio is in top 10 stocks. MIST proved to be the most loss making stock for the portfolio. MLTX was the most profitable stock for Lion Point Capital, LP last quarter.

$16.73MTotal Value

39.00Positions

15 May, 2026Last Reported

Current holdings of Current Stock Holdings of Lion Point Capital, LP, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
ARDX Ardelyx Inc Ardelyx IncARDX Lion Point Capital, LP's holding in Ardelyx Inc over time	4.61%	128,650	$770.6K 4.61%	unchanged 0 percentunchanged

ARQT Arcutis Biotherapeutics Inc Arcutis Biotherapeutics IncARQT Lion Point Capital, LP's holding in Arcutis Biotherapeutics Inc over time	0.74%	5,250	$123.7K 0.74%	unchanged 0 percentunchanged

AZTA Azenta Inc Azenta IncAZTA Lion Point Capital, LP's holding in Azenta Inc over time	1.23%	9,700	$205.0K 1.23%	unchanged 0 percentunchanged

BBIO Bridgebio Pharma Inc Bridgebio Pharma IncBBIO Lion Point Capital, LP's holding in Bridgebio Pharma Inc over time	2.22%	5,000	$371.3K 2.22%	unchanged 0 percentunchanged

BNTC Benitec Biopharma Inc Benitec Biopharma IncBNTC Lion Point Capital, LP's holding in Benitec Biopharma Inc over time	3.95%	62,000	$660.3K 3.95%	unchanged 0 percentunchanged

CMPS Compass Pathways Plc Compass Pathways Plc CMPS Lion Point Capital, LP's holding in Compass Pathways Plc over time	2.64%	80,000	$442.4K 2.64%	increased 37.93 percentadded

CUE Cue Biopharma Inc Cue Biopharma IncCUE Lion Point Capital, LP's holding in Cue Biopharma Inc over time	3.03%	73,428	$506.4K 3.03%	unchanged 0 percentunchanged

DAWN Day One Biopharmaceuticals I Day One Biopharmaceuticals IDAWN Lion Point Capital, LP's holding in Day One Biopharmaceuticals I over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

DYN Dyne Therapeutics Inc Dyne Therapeutics IncDYN Lion Point Capital, LP's holding in Dyne Therapeutics Inc over time	1.95%	18,000	$326.3K 1.95%	unchanged 0 percentunchanged

EWTX Edgewise Therapeutics Inc Edgewise Therapeutics IncEWTX Lion Point Capital, LP's holding in Edgewise Therapeutics Inc over time	1.71%	9,100	$286.6K 1.71%	unchanged 0 percentunchanged

FENC Fennec Pharmaceuticals Inc Fennec Pharmaceuticals IncFENC Lion Point Capital, LP's holding in Fennec Pharmaceuticals Inc over time	4.13%	112,434	$691.5K 4.13%	unchanged 0 percentunchanged

GERN Geron Corp Geron CorpGERN Lion Point Capital, LP's holding in Geron Corp over time	5.15%	578,000	$861.2K 5.15%	unchanged 0 percentunchanged

GHRS Gh Research Plc Gh Research Plc GHRS Lion Point Capital, LP's holding in Gh Research Plc over time	0.86%	10,200	$143.4K 0.86%	unchanged 0 percentunchanged

HUMA Humacyte Inc Humacyte IncHUMA Lion Point Capital, LP's holding in Humacyte Inc over time	2.36%	650,000	$394.4K 2.36%	increased 30 percentadded

INVA Innoviva Inc Innoviva IncINVA Lion Point Capital, LP's holding in Innoviva Inc over time	1.14%	8,200	$191.1K 1.14%	unchanged 0 percentunchanged

IPHA Innate Pharma S A Innate Pharma S A IPHA Lion Point Capital, LP's holding in Innate Pharma S A over time	0.62%	81,151	$103.9K 0.62%	unchanged 0 percentunchanged

JANX Janux Therapeutics Inc Janux Therapeutics IncJANX Lion Point Capital, LP's holding in Janux Therapeutics Inc over time	1.58%	19,000	$264.1K 1.58%	unchanged 0 percentunchanged

JSPR Jasper Therapeutics Inc Jasper Therapeutics IncJSPR Lion Point Capital, LP's holding in Jasper Therapeutics Inc over time	2.44%	465,000	$407.4K 2.44%	unchanged 0 percentunchanged

KURA Kura Oncology Inc Kura Oncology IncKURA Lion Point Capital, LP's holding in Kura Oncology Inc over time	2.23%	46,000	$374.0K 2.23%	unchanged 0 percentunchanged

LNTH Lantheus Hldgs Inc Lantheus Hldgs IncLNTH Lion Point Capital, LP's holding in Lantheus Hldgs Inc over time	2.49%	5,500	$417.2K 2.49%	unchanged 0 percentunchanged